Search results
Showing 6151 to 6165 of 7691 results
New study shows NICE Advice support can reduce appraisal timelines by 3 months Companies who receive scientific advice from our NICE Advice service...
New study shows NICE Advice support can reduce appraisal timelines by 3 months
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.
Planning for the International Recognition Procedure 5 ways NICE Advice can help you navigate this new opportunity alongside health technology...
Consultation on updated guideline to assess and prevent falls in older people
We're seeking views from healthcare professionals and the public on draft recommendations covering assessments and interventions to reduce the risk of falls in older people.
Consultation on NHS England proposals for a phased launch of obesity injection
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.
Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics.
We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy.
If you have any queries, please contact nice@nice.org.uk.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.
Process manual for the endorsement of guidance and quality standard support resources (PMG29)
The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.
This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics.
We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy.
If you have any queries, please contact nice@nice.org.uk.
This guidance has been updated and replaced by NICE diagnostics guidance 44.
This guidance has been updated and replaced by NICE guideline NG130.
Myocardial infarction with ST-segment elevation: acute management (CG167)
This guideline has been updated and replaced by NICE guideline NG185.